Epitel
Salt Lake City, UtahFounded 2014
- EEG and neural monitoring
- Wearables
- Series B
Epitel is a digital health company developing wearable EEG monitoring solutions to make brain health monitoring more accessible. Its REMI platform supports EEG monitoring in healthcare facilities and ambulatory settings, while REMI Vigilenz AI helps physicians identify EEG segments that may correspond to neurological events.
- RaisedTotal raised
- $49.5M
- Jul 2026Latest priced round, Jul 2026
- Series B
- Investors
- 9
- Founded
- 2014
- Employees
- 11–50
reccy insights
On August 17, 2026, Epitel announced a partnership with Stratus aimed at expanding EEG access for patients with seizure disorders. On August 13, the company announced work with INVI MindHealth to bring 24-hour EEG brain monitoring into veteran mental health research. These collaborations followed Epitel’s $26 million Series B, announced July 28, 2026, with Catalyst Health Ventures identified as lead investor and Genoa Ventures also participating. The funding supports expansion of remote wireless EEG monitoring. Earlier milestones include Steve Pacelli’s appointment as CEO on February 13, 2025, succeeding founder Mark Lehmkuhle, who transitioned to Chief Technology Officer. Epitel’s medical monitoring technology was also recognized in The Scientist’s 2024 Top 10 Innovations, announced December 13, 2024. Together, the partnership announcements, leadership transition, financing and award point to continued efforts to broaden clinical and research use of the company’s EEG platform.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes Epitel distinct
- 01Combines wearable EEG sensors, mobile software and secure cloud storage in a remote monitoring platform.
- 02Supports EEG monitoring in healthcare facilities and ambulatory settings, with sensor use lasting up to 30 days.
- 03Designed for adult and pediatric patients; REMI is indicated for patients aged 1 and older.
- 04REMI Vigilenz AI flags previously recorded EEG sections that may correspond to neurological events for review by qualified physicians.
- 05The team brings experience across medical devices, computational neuroscience, data science, regulatory affairs and healthcare commercialization.
Technology & products2
- REMI™ Remote EEG Monitoring System
A wearable, wireless EEG system that captures and transmits brain electrical activity for up to 30 days, enabling near real-time and remote monitoring in healthcare and ambulatory settings.
- REMI Vigilenz™ AI for Event Detection
An AI software tool that analyzes REMI EEG recordings to identify and annotate potential electrographic seizure events for physician review.
- REMI Remote EEG Monitoring System
- REMI wearable wireless EEG sensors
- REMI Mobile software application
- REMI Cloud
- REMI Vigilenz AI for Event Detection
Recent updates4
- Aug 17, 2026Partnership
Epitel partnered with Stratus to expand EEG access for patients with seizure disorders.
prweb.com - Aug 13, 2026Partnership
Epitel and INVI MindHealth announced a collaboration to bring 24-hour EEG brain monitoring to veteran mental health research.
prweb.com - Feb 13, 2025Team change
Steve Pacelli was appointed CEO of Epitel, succeeding Mark Lehmkuhle, who transitioned to Chief Technology Officer.
businesswire.com
In the Cortex
- Jeff Huynh Joins Epitel as Director of MarketingEpitel on LinkedIn · Jan 13, 2026
Funding
- Series BJul 2026$26MLed by Catalyst Health Ventures
- Venture RoundMar 2025$3.1M
- Series AFeb 2022$12.5MLed by Catalyst Health Ventures, Genoa Ventures
Similar companies
About Epitel
- Products
- REMI™ Remote EEG Monitoring System, REMI Vigilenz™ AI for Event Detection
- Leadership
- Mark Lehmkuhle, CTONico Choksi, COOSteve Pacelli, CEO
- Focus areas
- Digital health, medical devices, EEG, neurology, seizure monitoring, wearables, AI, remote patient monitoring
- Headquarters
- Salt Lake City, Utah
- Founded
- 2014
- Employees
- 11–50
- Patents granted
- 21
- Trademarks
- 9